United States · FDA National Drug Code directory
Amifostine Trihydrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84684-001_4eefd97c-ff55-6499-e063-6294a90aadce
- Product NDC
- 84684-001
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Amifostine Trihydrate
- Labeler
- Symbiosis Pharmaceutical Services Limited
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20260316
- Source listing expiry
- 20271231
Source-listed ingredients
- AMIFOSTINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (84684-001-01) · 84684-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →